1
/
of
0
FDA Drug Approval, N021359, RECTIV
FDA Drug Approval, N021359, RECTIV
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
NDA: 021359
Company: ABBVIE
Drug Name: RECTIV
Active Ingredients: NITROGLYCERIN
Strength: OINTMENT;INTRA-ANAL
Dosage Form/Route: Prescription
Action Date: ORIG-1
Marketing Status: AB
Submission Classification: PRIORITY
Company: ABBVIE
Drug Name: RECTIV
Active Ingredients: NITROGLYCERIN
Strength: OINTMENT;INTRA-ANAL
Dosage Form/Route: Prescription
Action Date: ORIG-1
Marketing Status: AB
Submission Classification: PRIORITY
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details